| Abstract: |
The implementation and integration of systems biology approaches with the emerging nanosciences and microchip technology will profoundly revolutionize molecular imaging and fuel the drive toward a more predictive and individualized health care. In combination with informatics platforms, key gene and protein targets may be identified that will serve as more effective targets for diagnostic and therapeutic interventions. Drug development may additionally be expedited by the judicious selection of more appropriate molecular biomarkers that will serve as objective endpoints of treatment efficacy. Finally, with the more widespread proliferation of high field magnets and advancements in imaging hardware, acquisition methods, and novel, “smart” MR agents, the ability to achieve higher resolution analyses of tumor biology, cell tracking, and gene expression will be more fully realized. © The Author(s), under exclusive license to Springer Nature Switzerland AG 2023. |
